Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2014
07/09/2014CN103910797A 鼠抗人znf580单克隆抗体 Mouse anti-human monoclonal antibody znf580
07/09/2014CN103910796A 一种全人源抗狂犬病毒的中和抗体 One kind of fully human anti-rabies virus neutralizing antibodies
07/09/2014CN103910795A 抗玻勒虹彩病毒的单克隆抗体及其应用 Le iridescent glass anti-virus monoclonal antibody and its application
07/09/2014CN103908669A 磷酸胆碱偶联物和相应抗体 Phosphorylcholine conjugate and corresponding antibodies
07/09/2014CN103342752B 一种抗人组织因子单链抗体及其制备方法 A single-chain antibody against human tissue factor and its preparation method
07/09/2014CN103333248B 一种cd25纳米抗体、其编码序列及应用 One kind cd25 Nanobody coding sequence and Applications
07/09/2014CN103060275B 一种抗氯胺酮杂交瘤细胞株及其制备方法和应用 Ketamine, an anti-hybridoma cell line and its preparation method and application
07/09/2014CN103044551B 一种防治自然流产的单克隆抗体及其应用 A spontaneous abortion prevention and application of monoclonal antibodies
07/09/2014CN102776152B 抗蓝舌病病毒vp7蛋白的单克隆抗体，分泌该抗体的杂交瘤细胞株及应用 Bluetongue virus anti vp7 protein monoclonal antibody secreting hybridoma cell lines and the application of the antibody
07/09/2014CN102731655B 鹅免疫球蛋白编码区及其恒定区特异性单克隆抗体与应用 Specific monoclonal antibodies and Application goose immunoglobulin constant region and the coding region
07/09/2014CN102373214B 具有增加的Fc受体结合亲和性和效应子功能的CD20抗体 Having increased Fc receptor binding affinity and effector function of a CD20 antibody
07/09/2014CN102308216B 免疫球蛋白糖基化模式分析 Immunoglobulin glycosylation pattern analysis
07/09/2014CN102239182B MUC1<sup>*</sup>抗体 MUC1 <sup> * </ sup> antibody
07/09/2014CN102037017B Il-17ra-il-17rb拮抗物及其用途 Il-17ra-il-17rb antagonists and uses thereof
07/09/2014CN101952318B 抗nr10抗体及其应用 Anti-nr10 antibody and its application
07/09/2014CN101809035B 能结合胸腺基质淋巴细胞生成素的抗原结合蛋白 Can combine thymic stromal cell antigen binding protein erythropoietin
07/09/2014CN101663047B 通过激活或阻断HLA-E/Qa-1限制性CD8+T细胞调控途径来治疗免疫疾病的方法 By activating or blocking HLA-E / Qa-1 restricted CD8 + T cell regulatory pathways method for treating autoimmune diseases
07/09/2014CN101653603B 磷脂酰乙醇胺结合肽缀合物及其治疗病毒感染的用途 Phosphatidylethanolamine binding peptide conjugates and their use to treat viral infections
07/08/2014US8772461 Two-stage ultrafiltration/diafiltration
07/08/2014US8772460 Thermostable FGF-2 mutant having enhanced stability
07/08/2014US8772459 J591 minibodies and Cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use
07/08/2014US8772458 Crystalline anti-hTNFalpha antibodies
07/08/2014US8772457 BACE1 antibodies
07/08/2014US8772448 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
07/08/2014US8772246 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
07/08/2014US8772244 Tubulin inhibitors
07/08/2014US8772229 Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase as potential therapeutic agents for obesity and diabetes
07/08/2014US8772026 Enhancement of immune responses by 4-1 BB-binding agents
07/08/2014US8771989 Vectors and yeast strains for protein production: Ca2+ ATPase overexpression
07/08/2014US8771960 Method for producing protein libraries and for selecting proteins from said libraries
07/08/2014US8771932 Rationally designed antibodies
07/08/2014US8771698 Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection
07/08/2014US8771696 Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor
07/08/2014US8771694 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
07/08/2014US8771693 Methods and compositions for the generation and use of conformation-specific antibodies
07/08/2014US8771692 Methods for treatment of muscular dystrophy
07/08/2014US8771686 Methods for treating a disease involving choroidal neovascularization by administering an IL-6 receptor antibody
07/08/2014US8771424 Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose
07/08/2014CA2745904C Sparc binding peptides and uses thereof
07/08/2014CA2666682C Anti-il-13r.alpha.1 antibodies and their uses thereof
07/08/2014CA2638849C Antibodies that bind par-2
07/08/2014CA2628900C Monoclonal antibodies against .beta.3 integrins
07/08/2014CA2619443C Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
07/08/2014CA2604933C Methods and compositions for modulating and detecting wisp activity
07/08/2014CA2595800C Specific binding members for ngf
07/08/2014CA2584211C Methods for refolding of recombinant antibodies
07/08/2014CA2549982C Engineered templates and their use in single primer amplification
07/08/2014CA2548792C Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
07/08/2014CA2547165C Mutated anti-cd22 antibodies and immunoconjugates
07/08/2014CA2545653C Asymmetrically branched polymer conjugates and microarray assays
07/08/2014CA2468753C Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
07/08/2014CA2417568C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
07/08/2014CA2415422C Chromosome 3p21.3 genes are tumor suppressors
07/08/2014CA2395369C Cytokine zcyto18
07/08/2014CA2348657C Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia
07/03/2014WO2014106235A1 Anti-granulysin antibodies and methods of use thereof
07/03/2014WO2014106176A1 Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
07/03/2014WO2014106116A2 Delivery of biologic therapeutics
07/03/2014WO2014106104A1 Use of dr6 antagonists to improve motor neuron disease
07/03/2014WO2014106015A2 Multivalent binding protein compositions
07/03/2014WO2014106004A2 High-throughput system and method for identifying antibodies having specific antigen binding activities
07/03/2014WO2014106001A2 Dual specific binding proteins having a receptor sequence
07/03/2014WO2014105966A2 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
07/03/2014WO2014105849A1 Antibodies specific for fgfr4 and methods of use
07/03/2014WO2014105810A1 Prolactin receptor binding proteins and uses thereof
07/03/2014WO2014104270A1 ANTIBODY RECOGNIZING FOLATE RECEPTORS α AND β
07/03/2014WO2014104165A1 Heterodimerized polypeptide
07/03/2014WO2014102430A1 Therapeutic treatment of t- and b-acute lymphoblastic leukemia and human lymphomas by inhibition of the interleukin-7 receptor (il-7r)
07/03/2014WO2014102399A1 Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
07/03/2014WO2014102370A1 High temperature dead end antibody filtration
07/03/2014WO2014102104A1 Artificial introns
07/03/2014WO2014102101A1 Novel intron sequences
07/03/2014WO2014102100A1 Heterologous intron within an immunoglobulin domain
07/03/2014WO2014074528A3 Combination therapies using anti-pseudomonas psl and pcrv binding molecules
07/03/2014WO2012170071A8 Mcam antagonists and methods of treatment
07/03/2014US20140187756 Methods of preparing antibody-active agent conjugates
07/03/2014US20140187755 Clostridial neurotoxins with altered persistency
07/03/2014US20140187754 Anti-fgfr3 antibodies and methods using same
07/03/2014US20140187753 Hetero-Dimeric Immunoglobulins
07/03/2014US20140187752 Antigenic compositions and use of same in the targeted delivery of nucleic acids
07/03/2014US20140187751 Purification of fusion proteins
07/03/2014US20140187491 Relaxin fusion polypeptides and uses thereof
07/03/2014US20140187485 Novel receptor nucleic acids and polypeptides
07/03/2014US20140186943 NUCLEIC ACIDS ENCODING A HUMAN MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO IL-1a
07/03/2014US20140186917 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt
07/03/2014US20140186892 Monoclonal antibodies against glypican-3
07/03/2014US20140186891 Polynucleotides encoding il-31 monoclonal antibodies
07/03/2014US20140186890 Selection of host cells expressing protein at high levels
07/03/2014US20140186889 Antibody generation from plasmacytoma-prone transgenic animals
07/03/2014US20140186887 RECEPTOR ACTIVATOR OF NF-kappaB
07/03/2014US20140186867 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
07/03/2014US20140186860 Novel immunogenic proteins of leptospira
07/03/2014US20140186446 Delivery of Biologic Therapeutics
07/03/2014US20140186383 Novel simian t-cell lymphotropic virus
07/03/2014US20140186377 Prostaglandin e2 binding proteins and uses thereof
07/03/2014US20140186376 Compositions and Methods for Inhibiting CCL3
07/03/2014US20140186373 Antibody formulation
07/03/2014US20140186371 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
07/03/2014US20140186370 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
07/03/2014US20140186369 Method of modulating neovascularization
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 1494